NCT02288962View on ClinicalTrials.gov

Dopamine Agonist Treatment of Non-functioning Pituitary Adenomas

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2028

Conditions
Pituitary NeoplasmsAdenoma
Interventions
DRUG

cabergoline

Trial Locations (3)

7006

Department of Endocrinology, St. Olavs Hospital, Trondheim

Unknown

Department of Endocrinology, Akershus University hospital, Oslo

Sahlgrenska University Hospital, Gothenburg

All Listed Sponsors
collaborator

Norwegian University of Science and Technology

OTHER

lead

St. Olavs Hospital

OTHER